ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Clinical features and diagnosis of bacterial sepsis in preterm infants <34 weeks gestation

Clinical features and diagnosis of bacterial sepsis in preterm infants <34 weeks gestation
Literature review current through: May 2024.
This topic last updated: Feb 15, 2024.

INTRODUCTION — Neonatal sepsis remains a major cause of neonatal mortality and morbidity in preterm and very low birth weight (VLBW) infants.

The clinical features and diagnosis of bacterial sepsis in the preterm infant will be reviewed here. The management and prevention of bacterial sepsis in the preterm infant are discussed separately. (See "Treatment and prevention of bacterial sepsis in preterm infants <34 weeks gestation".)

Sepsis in term and late preterm neonates is discussed separately. (See "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates" and "Management and outcome of sepsis in term and late preterm neonates".)

TERMINOLOGY — The following terms will be used throughout this topic:

Preterm infants are those born at <34 weeks gestation.

Late preterm infants (also called near-term infants) are those born between 34 and 36 completed weeks of gestation. Sepsis in late preterm infants is discussed in a separate topic review. (See "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates".)

Very low birth weight (VLBW) infants are those with birth weights <1500 g.

Sepsis is defined as isolation of a pathogenic bacterium from a blood culture in a patient with signs or symptoms consistent with clinical sepsis.

Early-onset sepsis (EOS) is defined as sepsis that occurs within the first 72 hours after birth

Late-onset sepsis (LOS) is defined as sepsis that occurs at >72 hours of after birth

Health care-associated infections are defined as infections (eg, sepsis) acquired in the hospital while receiving treatment for other conditions [1].

PATHOGENESIS

Early-onset sepsis (EOS) — Early-onset infection is usually due to vertical transmission by ascending contaminated amniotic fluid or during vaginal delivery from bacteria colonizing or infecting the mother's lower genital tract [2]. The risk for sepsis increases substantially in neonates born to mothers with intra-amniotic infection (also called chorioamnionitis). (See 'Maternal risk factors for EOS' below.)

Maternal group B streptococcal (GBS) bacteriuria during the current pregnancy, prior delivery of an infant with GBS disease, and maternal colonization are some risk factors for early-onset GBS sepsis. Risk factors for GBS infection are discussed in greater detail separately. (See "Group B streptococcal infection in neonates and young infants", section on 'Risk factors'.)

Late-onset sepsis (LOS) — Late-onset infections can be acquired by the two following mechanisms:

Maternal vertical transmission, resulting in initial neonatal colonization that evolves into later infection.

Horizontal transmission from direct contact with care providers or environmental sources (ie, health care-associated infections). Disruption of the intact skin or mucosa, which can be due to invasive procedures (eg, intravascular catheter), increases the risk of late-onset infection. (See 'Risk factors' below.)

INCIDENCE — The risk of sepsis increases with decreasing gestational age and birth weight [3-7]. In the United States, estimated rates of culture-proven sepsis among preterm very low birth weight (VLBW) infants are as follows:

Early-onset sepsis (EOS) [6,8,9]:

According to gestational age:

-Gestational age ≤25 weeks – 3.1 percent

-Gestational age 26 to 29 weeks – 1.2 percent

-Gestational age >29 weeks – 0.5 percent

According to birth weight:

-Birth weight <400 to 500 g – 2 percent

-Birth weight 501 to 750 g – 2.5 percent

-Birth weight 751 to 1000 g – 1.7 percent

-Birth weight 1001 to 1250 g – 1 percent

-Birth weight 1251 to 1500 g – 0.7 percent

Late-onset sepsis (LOS) [6,7]:

According to gestational age:

-Gestational age ≤23 weeks – 32 percent

-Gestational age 24 to 25 weeks – 22 percent

-Gestational age 26 to 27 weeks – 11 percent

-Gestational age 28 to 29 weeks – 5 percent

-Gestational age >29 weeks – 2 percent

According to birth weight:

-Birth weight <400 to 500 g – 43 percent

-Birth weight 501 to 750 g – 43 percent

-Birth weight 751 to 1000 g – 28 percent

-Birth weight 1001 to 1250 g – 15 percent

-Birth weight 1251 to 1500 g – 7 percent

These incidence rates are based on data from two prospective registries in the United States (the National Institute of Child Health and Human Development Neonatal Research Network and the Vermont Oxford Network). Registries of preterm infants born in other developed countries (including Canada, England, Germany, Israel, Australia, and New Zealand) have yielded similar estimates [4,5,10-13].

The incidence of EOS in VLBW infants has remained stable since the 1990s; however, the incidence of LOS has decreased since the early 2000s among preterm infants in each gestational age category [6].

MICROBIOLOGY

Pathogens in EOS — Escherichia coli and group B streptococcus (GBS) are the most common causes of neonatal early-onset sepsis (EOS) (table 1) [5,8]. In very preterm infants, E. coli is more common as an EOS pathogen compared with GBS [4,5,8,14]. This was illustrated in a study from the National Institute of Child Health and Human Development (NICHD) registry, in which the incidences of EOS due to E. coli and GBS in very low birth weight (VLBW) infants were 8.1 and 1.6 per 1000 live births, respectively [8]. For larger preterm infants with birth weights between 1500 and 2500 g, the incidences were 0.7 and 0.3 per 1000 live births, respectively [8]. In a study from the Canadian Neonatal Network (CNN), similar to studies from other countries, E. coli and GBS were among the most common pathogens [4]. In this study, coagulase-negative staphylococci (CoNS) were also commonly isolated. The relevance of CoNS as a pathogen in EOS is discussed below. (See 'CoNS: Pathogen or contaminant?' below.)

Pathogens in LOS

Bacterial pathogens – In preterm infants, the most common pathogens associated with late-onset sepsis (LOS) are CoNS, Staphylococcus aureus, and gram-negative bacteria (E. coli, Klebsiella, Enterobacter) (table 1). In a prospective observational study of very preterm infants born from 2018 through 2020, the relative frequencies of different bacterial pathogens among the 10,501 infants with LOS were as follows [7]:

CoNS (29 percent)

S. aureus (23 percent)

E. coli (12 percent)

Klebsiella (8 percent)

Enterococcus (5 percent)

GBS (5 percent)

Enterobacter (4 percent)

Pseudomonas (3 percent)

Serratia (2 percent)

Similar findings were noted in a report based on data from the national neonatal infection surveillance system in Germany [15].

Nonbacterial pathogens – Viral and fungal infections are also important causes of late-onset infections in preterm neonates. These pathogens are discussed separately:

(See "Neonatal herpes simplex virus infection: Clinical features and diagnosis".)

(See "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'.)

(See "Candida infections in neonates: Epidemiology, clinical manifestations, and diagnosis".)

(See "Unusual fungal infections in the neonate".)

CoNS: Pathogen or contaminant? — While CoNS is commonly isolated in culture in preterm neonates, it may or may not reflect true infection. In some cases, the positive culture may be due to contamination or colonization of a catheter hub (eg, when blood cultures are drawn from indwelling catheters).

The challenge of distinguishing true CoNS neonatal infection was illustrated in a retrospective study from a single tertiary center that identified 134 neonates with 149 episodes of positive CoNS culture from blood or a usual sterile site [16]. Of these, 27 percent were considered proven infection (defined as two positive cultures and ≥2 clinical signs of sepsis [temperature instability, cardiorespiratory or gastrointestinal disturbances, lethargy or irritability]), 37 percent were considered probable infection (based upon blinded review of clinical and laboratory data by two pediatric infectious disease specialists), and 36 percent were felt to reflect contamination. In this cohort, risk factors for proven and probable CoNS infection included birth weight <2000 g, gestational age <34 weeks, and presence of a central venous catheter.

CoNS is most relevant as a pathogen in LOS; the importance of CoNS as a pathogen in EOS is unclear. The two studies described above (from the NICHD and CNN registries) reported markedly different rates of EOS due to CoNS. In the NICHD study, CoNS accounted for <1 percent of EOS cases; whereas in the CNN study, CoNS accounted for 11 percent of cases of EOS in preterm neonates [4,8]. These disparate findings are likely explained by differences in how EOS was defined in each study. In the NICHD study, CoNS was considered a contaminant unless it was isolated in ≥2 separate cultures and the infant received ≥5 days of antibiotic therapy, whereas the CNN study considered any positive culture a case of EOS [4,8].

Obtaining two blood cultures can help to distinguish between true CoNS infection versus contaminant, as discussed below. (See 'Blood culture' below.)

RISK FACTORS

Risk factors associated with prematurity — Preterm infants are at increased risk for developing sepsis compared with term infants for the following reasons [1,13,17-19]:

Immunocompromised host – Preterm infants have low levels of circulating maternal immunoglobulin G (IgG) because of the loss of transplacental transfer that occurs during the third trimester of pregnancy. Even in the presence of adequate IgG concentrations, opsonization and complement functions are reduced in preterm infants.

Epithelial mucosal barrier – The epithelial barriers in preterm infants are immature. In these infants, the skin and mucosal barriers are thin and delicate, readily break down, and provide minimal protection. Therapeutic interventions that increase the risk of health care-associated (ie, nosocomial) infection are more likely to be used in preterm infants [1,20].

Invasive devices – Invasive devices, such as central venous catheters (CVCs), arterial catheters, urinary catheters, and endotracheal tubes further compromise the epithelial barrier. The risk increased the longer these devices remain in situ. The use of invasive devices increases with decreasing gestational age, thereby compounding the risk of infection in the most preterm neonates.  

Parenteral nutrition – Parenteral nutrition administered through a CVC is associated with an increased risk of sepsis. The administration of lipids may also be an independent risk factor for bacterial and fungal sepsis.

Gastric acid blockade – Use of histamine-2 receptor blockers or proton pump inhibitors is associated with increased risk of sepsis [21].

Type of CVC (ie, peripherally inserted central catheter [PICC] versus UVC) does not appear to impact the risk of infection. In a retrospective matched cohort study of 540 preterm infants (<30 weeks gestation), the rates of catheter-associated bloodstream infection were similar among infants who received a PICC on the first day after birth (day 1), those who received a UVC on day 1, and those who received a UVC on day 1 that was then changed for a PICC after four days or more (9.3, 7.8, and 8.2 per 1000 catheter days, respectively) [22].

As discussed above, risk factors of coagulase-negative staphylococci (CoNS) neonatal infection included gestational age <34 weeks, birth weight <2000 g, and central venous line [16]. (See 'CoNS: Pathogen or contaminant?' above.)

Maternal risk factors for EOS — Maternal factors that are associated with an increased risk of EOS in the neonate, regardless of gestational age, include intra-amniotic infection (clinical chorioamnionitis), intrapartum maternal fever, maternal group B streptococcus (GBS) colonization, preterm birth, and prolonged rupture of the membranes (PROM). Though the duration of ruptured membranes is commonly considered when assessing the neonate's risk of infection, it is unclear whether PROM is an independent risk factor for sepsis in preterm infants in the absence of intra-amniotic infection [23].

These factors are particularly pertinent to GBS infection. The approach to identifying pregnancies at risk for neonatal EOS and indications for maternal intrapartum antibiotic prophylaxis (IAP) are discussed separately. (See "Prevention of early-onset group B streptococcal disease in neonates", section on 'Identification of pregnancies at increased risk for early-onset neonatal GBS' and "Prevention of early-onset group B streptococcal disease in neonates", section on 'Intrapartum antibiotic prophylaxis'.)

Maternal GBS screening and IAP reduce but do not eliminate the risk of GBS infection in the neonate.

CLINICAL MANIFESTATIONS

Signs and symptoms — In preterm infants, the spectrum of symptoms of neonatal sepsis ranges from nonspecific subtle findings (eg, mild increase in apnea) to fulminant septic shock.

Nonspecific signs observed in preterm infants with sepsis include [8,24]:

Respiratory distress that ranges from mild tachypnea to respiratory failure

Increased respiratory support requirement

Lethargy or hypotonia

Increase in apnea

Feeding intolerance

Temperature instability

Hypotension or evidence of poor perfusion

Increase in heart rate

Because the signs and symptoms of sepsis can be subtle and nonspecific, any deviation from an infant's usual pattern of activity or feeding should be regarded as a possible indication of systemic bacterial infection. This was illustrated in a retrospective review of preterm infants with culture-proven coagulase-negative staphylococci (CoNS) bacteremia in which most infants on the first day of sepsis had new-onset apnea or bradycardia or new or increased respiratory support needs [25].

The underlying etiologic agent may also influence the clinical presentation. For example, gram-negative sepsis can be associated with a fulminant course of severe sepsis and/or septic shock with a high risk of mortality [26].

Clinical signs associated with CoNS infection tend to be more subtle. In the previously mentioned study of neonatal CoNS infections, the most frequent presenting signs that prompted evaluation included hypoxia, apnea, bradycardia, lethargy, and increased gastric residuals [25].

Novel monitoring techniques using algorithms to detect pathologic heart rate variability, respiratory instability, and/or decrease spontaneous movement in the infant have shown promise in predicting onset of sepsis in preterm neonates [27]. However, further study is needed before this strategy is routinely used in clinical practice.

Severe sepsis and septic shock — Sepsis is considered severe when it is associated with cardiovascular or pulmonary compromise or multiorgan failure (ie, dysfunction in two or more organ systems).

Clinical findings of neonatal shock include (see "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Distributive shock'):

Cool extremities, acrocyanosis, and pallor

Changes in heart rate (initially tachycardia and, in the later stages, which may be terminal, bradycardia)

Neurologic changes such as lethargy, irritability, and nonresponsiveness

Hypotension

Oliguria

In the preterm infant, evidence suggests that systemic inflammation triggered by sepsis can contribute to the development of other neonatal morbidities such as necrotizing enterocolitis, bronchopulmonary dysplasia, and intraventricular hemorrhage [28-32]. (See "Neonatal necrotizing enterocolitis: Pathology and pathogenesis" and "Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis".)

Septic shock results in inadequate tissue perfusion and lactic acidosis. Shock in this setting is likely multifactorial, resulting from reduced systemic vascular resistance, reduced circulating intravascular volume due to capillary leak and third spacing, and, potentially, myocardial dysfunction. (See "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Distributive shock'.)

EVALUATION

Clinical approach

Early-onset (first 72 hours) — For preterm neonates, cardiorespiratory instability is common during the transitional period after delivery. Distinguishing between these expected findings and clinical signs of EOS can be challenging in this population. Thus, the first step in the evaluation of suspected EOS in preterm neonates is assessing the risk of infection.

The approach to EOS risk assessment in preterm neonates is based upon the circumstances leading to preterm birth and the clinical condition of the newborn (algorithm 1) [33-36]:

High-risk – Preterm neonates born by vaginal or cesarean delivery due to spontaneous preterm labor, preterm prelabor rupture of membranes (PPROM), unexplained nonreassuring fetal status, or other concern for intra-amniotic infection are at the highest risk for EOS. These neonates warrant laboratory evaluation for sepsis and empiric antibiotic therapy pending cultures. (See 'Laboratory evaluation' below and "Treatment and prevention of bacterial sepsis in preterm infants <34 weeks gestation", section on 'Empiric antibiotic therapy'.)

Moderate-risk – Preterm neonates born due to maternal or fetal concerns (such as maternal preeclampsia, other maternal medical illness, fetal growth restriction, or placental insufficiency) who are born by vaginal or cesarean delivery after attempts to induce labor are at moderate risk for EOS. For these neonates, we suggest laboratory evaluation and empiric antibiotics in any of the following circumstances (see 'Laboratory evaluation' below and "Treatment and prevention of bacterial sepsis in preterm infants <34 weeks gestation", section on 'Empiric antibiotic therapy'):

If the infant is ill-appearing or has clinical instability that persists despite appropriate delivery room stabilization

If the mother had an indication for intrapartum antibiotic prophylaxis (IAP) but did not receive adequate IAP prior to delivery

If concern for intra-amniotic infection arose during delivery

Lower-risk – Preterm neonates born due to maternal or fetal concerns (such as maternal preeclampsia, other maternal medical illness, fetal growth restriction, or placental insufficiency) who are born by cesarean delivery without any attempt to induce labor with ROM at delivery are at the lowest risk for EOS. For most neonates in this category, we suggest clinical monitoring (with or without obtaining a blood culture) without empiric antibiotics. For neonates who have significant clinical instability that does not improve after initial delivery room stabilization, it is generally appropriate to perform laboratory evaluation for sepsis and administer empiric antibiotics. (See 'Laboratory evaluation' below and "Treatment and prevention of bacterial sepsis in preterm infants <34 weeks gestation", section on 'Empiric antibiotic therapy'.)

Risk stratification schemas for EOS that are routinely used in term infants (eg, the EOS calculator) are not appropriate for assessing risk in for preterm infants.

Late onset (>72 hours) — Because the signs and symptoms of sepsis are subtle and nonspecific, laboratory evaluation is performed in any infant with physical findings consistent with LOS or who deviates significantly from the usual pattern of activity or feeding. Empiric antibiotic therapy is provided pending culture results. (See "Treatment and prevention of bacterial sepsis in preterm infants <34 weeks gestation", section on 'Empiric antibiotic therapy'.)

Laboratory evaluation

Blood culture — The definitive diagnosis of neonatal sepsis is established with blood cultures, which can be obtained by venous or arterial puncture or by sampling from a newly inserted arterial or venous catheter.

Volume of blood – The sensitivity of blood culture to detect bacteremia depends upon using an adequate volume of blood to inoculate the culture bottle [37-39]. A minimum volume of 1 mL of blood is required for blood cultures [2].

Number of cultures – Obtaining more than one blood culture is helpful in the interpretation of blood culture results. If coagulase-negative staphylococci (CoNS) are isolated from two or more blood cultures, true bacteremia is more likely than contamination of the specimen, which may be reflected by a single positive blood culture [16].

However, in preterm infants, because of the difficulty in obtaining an adequate blood volume for culture, the result from only a single positive blood culture may be available. In this setting, it is challenging to decide whether or not there is true infection from CoNS [1]. The clinician must decide on further management based on the clinical setting (eg, response to empiric therapy and clinical suspicion for infection based on gestational age and other risk factors [16]). (See 'CoNS: Pathogen or contaminant?' above.)

Impact of exposure to maternal intrapartum antibiotics – The available evidence suggests that exposure to intrapartum does not reduce the sensitivity of blood cultures to detect EOS in the neonate [40,41].

Other cultures — Cultures of other sites may be indicated in the preterm infant who is suspected of having sepsis.

Cerebrospinal fluid (CSF) culture – Lumbar puncture (LP) is not necessary for every preterm neonate undergoing sepsis evaluation if the index of suspicion for infection is low (eg, a neonate undergoing evaluation due to increased episodes of apnea who otherwise appears clinically well). However, LP should be performed if the neonate is ill appearing or has other concerning findings (irritability, bulging fontanelle, seizures). In addition, LP should be performed if the blood culture is positive. In some cases, it may not be feasible to perform LP because the neonate is too unstable to tolerate the procedure. In these cases, the LP should be deferred until the neonate is stable.

If LP is performed, CSF should be sent for cell count with differential, protein, glucose, Gram stain, culture, and molecular testing (if available). CSF findings that suggest meningitis include a pleocytosis (CSF white blood cell [WBC] count >15/microL) with neutrophilic predominance, elevated CSF protein, and low CSF glucose. The interpretation of CSF parameters in neonates is discussed in greater detail separately. (See "Bacterial meningitis in the neonate: Clinical features and diagnosis", section on 'Interpretation of CSF parameters'.)

Urine culture – Urine culture obtained by catheterization or bladder tap should be included in the evaluation for LOS (ie, onset at ≥72 hours after birth). A urine culture need not be routinely performed in the evaluation of suspected EOS (onset within the first 72 hours after birth) because a positive urine culture in this setting is a reflection of high-grade bacteremia rather than an isolated urinary tract infection. (See "Urinary tract infections in neonates".)

Other sites – In patients with late-onset infection, cultures should be obtained from any other potential foci of infection (eg, purulent eye drainage, skin lesions or pustules, tracheal aspirates in mechanically ventilated infants, pleural or peritoneal fluid, bone or joint aspiration).

Inflammatory markers — Efforts have not been successful in identifying tests that can accurately and rapidly predict neonatal sepsis while awaiting blood culture results. The most widely studied tests are neutrophil counts, C-reactive protein (CRP), and procalcitonin. Other tests that have been evaluated include interleukin-6, interleukin-8, and tumor necrosis factor-alpha levels; however, these studies are primarily used in the research setting and are not routinely available in hospital laboratories [42,43]. (See "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Laboratory tests'.)

Neutrophil counts – Both the absolute neutrophil and the ratio of immature to total neutrophil counts (I/T ratio) have been used as markers for neonatal sepsis. However, as is true for term and late preterm infants, these tests are not useful to accurately predict neonatal sepsis. (See "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Complete blood count'.)

This was illustrated in a multicenter study of 166,092 infants that included both term and preterm infants with a mean gestational age of 34.6 weeks who were suspected to have EOS [44]. Although the probability of a positive blood culture within the first three days of age increased with a low white blood cell count (<5000/microL), absolute neutropenia (<1000 neutrophils/microL), and an elevated I/T ratio, sensitivities of all indices were poor and insufficient to accurately diagnose neonatal sepsis.

In another analysis of the same cohort of patients, LOS was associated with both low and high white blood cell counts (<1000 and >50,000/microL), high absolute neutrophil count (>17,670/microL), elevated I/T ratio of 0.2 or higher, and low platelet count (<50,000/microL) [44]. However, the sensitivity of these indices was inadequate to reliably make the diagnosis of LOS.

C-reactive protein – CRP is an acute phase reactant synthesized in the liver that increases in inflammatory conditions, including sepsis. Although an elevated CRP (>1 mg/dL) is 90 percent sensitive in detecting neonatal sepsis, its poor specificity makes it a poor predictor for neonatal sepsis as it is elevated in other noninfectious inflammatory conditions (eg, maternal fever, fetal distress) [45]. CRP levels do not seem to be affected by gestational age [46], and serial CRPs have been found to be useful to follow resolution of infection and guide antibiotic therapy [43,47-50]. (See "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Other inflammatory markers'.)

Molecular diagnostic methods — Molecular techniques (eg, polymerase chain reaction [PCR]) may offer a reliable and more timely method for diagnosis than bacterial cultures as they have a more rapid turnaround time, require smaller sample volumes, and are not affected by the administration of antepartum antibiotics [51,52]. While molecular methods are increasingly used to assist in the diagnosis of central nervous system (CNS) infections in infants and children, there role in the routine evaluation of suspected neonatal sepsis (ie, to detect bacteremia) is limited.

The role of PCR testing in neonatal meningitis is discussed separately. (See "Bacterial meningitis in the neonate: Clinical features and diagnosis", section on 'Molecular methods'.)

Other studies — Other studies are often obtained to differentiate sepsis from conditions with similar presentations. (See 'Differential diagnosis' below.)

These include:

Chest radiography in patients with respiratory distress to differentiate from pneumonia and respiratory distress syndrome (see "Neonatal pneumonia" and "Respiratory distress syndrome (RDS) in the newborn: Clinical features and diagnosis")

Serum glucose to assess for hypoglycemia (see "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia", section on 'Clinical presentation')

Metabolic screening to differentiate from inborn errors of metabolism (see "Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features" and "Metabolic emergencies in suspected inborn errors of metabolism: Presentation, evaluation, and management")

Pulse oximetry screening and echocardiography to differentiate from critical congenital heart disease (see "Identifying newborns with critical congenital heart disease")

DIAGNOSIS

Culture-proven sepsis — The diagnosis of sepsis is based upon isolating a pathogenic organism in culture (see 'Blood culture' above). Only a small fraction of neonates who undergo sepsis evaluation are ultimately diagnosed with proven sepsis.

Unlikely infection — Neonates with mild and/or transient symptoms who have negative cultures at 36 to 48 hours are unlikely to have sepsis. Empiric antibiotic therapy should be discontinued after 36 to 48 hours in these neonates.

The dilemma of "culture-negative sepsis" — "Culture-negative sepsis" is a term that has been used to describe neonates who have sterile blood cultures yet have a clinical course concerning for sepsis. These neonates are often presumed to have sepsis and treated with a full course of antibiotic therapy. However, this practice results in overdiagnosis of neonatal sepsis and overuse of antibiotics in preterm neonates [53-55]. This contributes to rising rates of drug-resistant bacteria in neonatal care units and it may have other adverse effects (eg, increased risk of necrotizing enterocolitis) [56,57]. (See "Neonatal necrotizing enterocolitis: Pathology and pathogenesis", section on 'Microbial dysbiosis'.)

Neonatal care providers should engage in efforts to limit the use of antibiotics in neonates with negative cultures, including the following:

Consider alternative etiologies – Neonates with ongoing concerning findings despite negative cultures should be evaluated for other possible explanations of their clinical findings (table 2). Viral infections (eg, enterovirus, parechovirus) are a particularly common nonbacterial cause of suspected sepsis in neonates. If a nonbacterial cause is identified, antibiotics should be discontinued. (See 'Differential diagnosis' below and "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'.)

Ensure adequate sampling for blood cultures – Properly obtained blood cultures are highly sensitive and specific for diagnosing neonatal sepsis. However, the sensitivity depends upon the volume of blood, as discussed above. (See 'Blood culture' above.)

Ensure that cultures are drawn before starting antibiotics.

Despite these efforts to reduce rates of culture-negative sepsis, some infants may fall into this category, and if no alternative diagnosis is established to explain the findings, a complete course of antibiotic therapy is reasonable for neonates with a clinical diagnosis of "probable sepsis." (See "Treatment and prevention of bacterial sepsis in preterm infants <34 weeks gestation", section on 'Antibiotic therapy'.)

DIFFERENTIAL DIAGNOSIS — Because the findings are nonspecific, it is often difficult to differentiate neonatal sepsis from other diseases. As a result, empiric antibiotic therapy is started until blood culture results are available. (See "Treatment and prevention of bacterial sepsis in preterm infants <34 weeks gestation", section on 'Empiric antibiotic therapy'.)

The differential diagnosis for neonatal sepsis in the preterm infant is broad and is similar to that for term or near-term newborns (table 2). It includes infectious and noninfectious etiologies:

Focal bacterial infections – Focal bacterial infections can occur with or without associated bacteremia. Examples include:

Urinary tract infection (see "Urinary tract infections in neonates")

Pneumonia (see "Neonatal pneumonia")

Meningitis (see "Bacterial meningitis in the neonate: Clinical features and diagnosis")

Cellulitis (see "Skin and soft tissue infections in neonates: Evaluation and management")

Nonbacterial infections – Nonbacterial infections that may mimic bacterial sepsis in preterm neonates include:

Fungal infection – Candidiasis (see "Candida infections in neonates: Epidemiology, clinical manifestations, and diagnosis")

Viral infections – Enteroviruses, herpes simplex virus, cytomegalovirus, influenza viruses, and respiratory syncytial virus (see "Neonatal herpes simplex virus infection: Clinical features and diagnosis" and "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates')

Spirochetal infections – Syphilis (see "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis")

Parasitic infections – Congenital malaria and toxoplasmosis (see "Congenital toxoplasmosis: Clinical features and diagnosis", section on 'Clinical features' and "Malaria in pregnancy: Epidemiology, clinical manifestations, diagnosis, and outcome", section on 'Vertical transmission')

Noninfectious etiologies – Noninfectious causes of cardiorespiratory instability in preterm neonates include:

Respiratory distress syndrome and other noninfectious causes of neonatal respiratory distress (table 3) (see "Respiratory distress syndrome (RDS) in the newborn: Clinical features and diagnosis")

Metabolic conditions (eg, hypoglycemia, inborn errors of metabolism) (see "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia" and "Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features")

Patent ductus arteriosus, if large in size (see "Patent ductus arteriosus (PDA) in preterm infants: Clinical features and diagnosis")

Critical congenital heart disease (see "Identifying newborns with critical congenital heart disease")

Side effects of certain medications (eg, opiates, prostaglandins, immunizations) (see "Diagnosis and initial management of cyanotic heart disease (CHD) in the newborn", section on 'Prostaglandin E1' and "Management and prevention of pain in neonates", section on 'Adverse effects')

Withdrawal from in utero substance exposure (ie, neonatal abstinence syndrome) (see "Neonatal abstinence syndrome (NAS): Clinical features and diagnosis")

Appropriate cultures and other microbiology studies usually distinguish neonatal bacterial sepsis from other types of infections or noninfectious conditions. (See 'Evaluation' above.)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Sepsis in neonates" and "Society guideline links: Group B streptococcal infection in pregnant women and neonates".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Sepsis in newborn babies (The Basics)")

SUMMARY AND RECOMMENDATIONS

Importance – Neonatal sepsis is a major cause of neonatal mortality and morbidity in preterm and very low birth weight (VLBW; <1500 g) infants. The risk of neonatal sepsis increases with decreasing gestational age (GA) and birth weight (BW). (See 'Introduction' above and 'Incidence' above.)

Early- versus late-onset infection – Neonatal sepsis is classified by the infant's age at the time of onset of symptoms:

Early-onset sepsis (EOS; onset within 72 hours after birth) – EOS occurs in approximately 1 to 2 percent of VLBW infants. It is due to vertically transmitted bacteria. Escherichia coli and Group B Streptococcus (GBS) are the most common pathogens (table 1). (See 'Early-onset sepsis (EOS)' above and 'Incidence' above and 'Pathogens in EOS' above.)

Late-onset sepsis (LOS; onset at >72 hours after birth) – LOS occurs in approximately 10 to 40 percent of VLBW infants, depending upon GA and BW. LOS is due to bacteria acquired at birth or from environmental horizontal transmission. Coagulase-negative staphylococci (CoNS), Staphylococcus aureus, and gram-negative bacteria (E. coli, Klebsiella,) are the most commonly isolated pathogens (table 1). (See 'Late-onset sepsis (LOS)' above and 'Incidence' above and 'Pathogens in LOS' above.)

Risk factors – Preterm infants are at higher risk of sepsis compared with term infants because they have decreased immunocompetence, their epithelial mucosal barrier is immature, and they are more likely to require invasive devices (eg, central venous catheters, mechanical ventilation). (See 'Risk factors associated with prematurity' above.)

Clinical manifestations – In preterm infants, the spectrum of symptoms of neonatal sepsis ranges from nonspecific subtle findings (eg, mild increase in apnea) to fulminant septic shock. The most frequent signs observed in preterm infants with sepsis include (see 'Clinical manifestations' above):

Respiratory distress and/or increase in respiratory support requirement

Lethargy or hypotonia

Increase in apnea

Feeding intolerance

Temperature instability

Increase in heart rate

Hypotension or evidence of poor perfusion

Evaluation

EOS – The approach to risk assessment for EOS is based upon the circumstances leading to preterm birth and the clinical condition of the newborn (algorithm 1). The risk is highest in the setting of preterm prelabor rupture of membranes (PPROM), unexplained nonreassuring fetal status, or other concern for intra-amniotic infection; these neonates warrant laboratory evaluation for sepsis and empiric antibiotic therapy pending cultures. The risk of EOS is lowest in those who are born by cesarean delivery without any attempt to induce labor with ROM at delivery; most neonates in this category can be clinically monitored without empiric antibiotics. (See 'Early-onset (first 72 hours)' above.)

LOS – Laboratory evaluation for sepsis is warranted in infants with physical findings consistent with LOS and those who deviate significantly from the usual pattern of activity or feeding. (See 'Late onset (>72 hours)' above.)

Tests to perform – At a minimum, the laboratory evaluation includes a blood culture. Other tests may include cerebrospinal culture and cell counts; urine culture (for infants >6 days of age); inflammatory markers (eg, C-reactive protein, white blood cell count with differential); chest radiograph (if there are respiratory symptoms); and cultures of any other potential foci of infection (eg, skin pustule, tracheal aspirates in mechanically ventilated infants). (See 'Laboratory evaluation' above.)

Empiric therapy – In most neonates who undergo laboratory evaluation due to clinical concern for sepsis, it is appropriate to initiate empiric antibiotic therapy while awaiting culture results. (See "Treatment and prevention of bacterial sepsis in preterm infants <34 weeks gestation", section on 'Empiric antibiotic therapy'.)

Diagnosis – The diagnosis of sepsis is based upon isolating a pathogenic organism in culture. (See 'Diagnosis' above.)

Differential diagnosis – The differential diagnosis of neonatal sepsis includes other systemic infections, inborn errors of metabolism, critical congenital heart disease, and neonatal respiratory distress. These conditions are differentiated from sepsis by the clinical history and laboratory evaluation, including culture. (See 'Differential diagnosis' above.)

  1. Polin RA, Denson S, Brady MT, et al. Epidemiology and diagnosis of health care-associated infections in the NICU. Pediatrics 2012; 129:e1104.
  2. Puopolo KM, Benitz WE, Zaoutis TE, et al. Management of Neonates Born at ≤34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics 2018; 142.
  3. Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127:817.
  4. Sgro M, Shah PS, Campbell D, et al. Early-onset neonatal sepsis: rate and organism pattern between 2003 and 2008. J Perinatol 2011; 31:794.
  5. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96:F9.
  6. Stoll BJ, Hansen NI, Bell EF, et al. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA 2015; 314:1039.
  7. Flannery DD, Edwards EM, Coggins SA, et al. Late-Onset Sepsis Among Very Preterm Infants. Pediatrics 2022; 150.
  8. Stoll BJ, Puopolo KM, Hansen NI, et al. Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies. JAMA Pediatr 2020; 174:e200593.
  9. Flannery DD, Edwards EM, Puopolo KM, Horbar JD. Early-Onset Sepsis Among Very Preterm Infants. Pediatrics 2021; 148.
  10. Makhoul IR, Sujov P, Smolkin T, et al. Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey. Clin Infect Dis 2005; 40:218.
  11. Daley AJ, Isaacs D, Australasian Study Group for Neonatal Infections. Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia. Pediatr Infect Dis J 2004; 23:630.
  12. Tröger B, Göpel W, Faust K, et al. Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network. Pediatr Infect Dis J 2014; 33:238.
  13. Köstlin-Gille N, Härtel C, Haug C, et al. Epidemiology of Early and Late Onset Neonatal Sepsis in Very Low Birthweight Infants: Data From the German Neonatal Network. Pediatr Infect Dis J 2021; 40:255.
  14. Rønnestad A, Abrahamsen TG, Medbø S, et al. Septicemia in the first week of life in a Norwegian national cohort of extremely premature infants. Pediatrics 2005; 115:e262.
  15. Piening BC, Geffers C, Gastmeier P, Schwab F. Pathogen-specific mortality in very low birth weight infants with primary bloodstream infection. PLoS One 2017; 12:e0180134.
  16. Healy CM, Baker CJ, Palazzi DL, et al. Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit. J Perinatol 2013; 33:52.
  17. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110:285.
  18. Greenberg RG, Kandefer S, Do BT, et al. Late-onset Sepsis in Extremely Premature Infants: 2000-2011. Pediatr Infect Dis J 2017; 36:774.
  19. Giannoni E, Agyeman PKA, Stocker M, et al. Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study. J Pediatr 2018; 201:106.
  20. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr 2001; 139:821.
  21. Santos VS, Freire MS, Santana RNS, et al. Association between histamine-2 receptor antagonists and adverse outcomes in neonates: A systematic review and meta-analysis. PLoS One 2019; 14:e0214135.
  22. Shalabi M, Adel M, Yoon E, et al. Risk of Infection Using Peripherally Inserted Central and Umbilical Catheters in Preterm Neonates. Pediatrics 2015; 136:1073.
  23. Ofman G, Vasco N, Cantey JB. Risk of Early-Onset Sepsis following Preterm, Prolonged Rupture of Membranes with or without Chorioamnionitis. Am J Perinatol 2016; 33:339.
  24. Bekhof J, Reitsma JB, Kok JH, Van Straaten IH. Clinical signs to identify late-onset sepsis in preterm infants. Eur J Pediatr 2013; 172:501.
  25. Maayan-Metzger A, Linder N, Marom D, et al. Clinical and laboratory impact of coagulase-negative staphylococci bacteremia in preterm infants. Acta Paediatr 2000; 89:690.
  26. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000; 106:1387.
  27. Joshi R, Kommers D, Oosterwijk L, et al. Predicting Neonatal Sepsis Using Features of Heart Rate Variability, Respiratory Characteristics, and ECG-Derived Estimates of Infant Motion. IEEE J Biomed Health Inform 2020; 24:681.
  28. Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006; 19:290.
  29. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999; 103:766.
  30. Harris MC, D'Angio CT, Gallagher PR, et al. Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr 2005; 147:462.
  31. Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003; 88:F209.
  32. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999; 158 Suppl 1:S18.
  33. Puopolo KM, Lynfield R, Cummings JJ, et al. Management of Infants at Risk for Group B Streptococcal Disease. Pediatrics 2019; 144.
  34. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999; 103:e77.
  35. Mukhopadhyay S, Puopolo KM. Clinical and Microbiologic Characteristics of Early-onset Sepsis Among Very Low Birth Weight Infants: Opportunities for Antibiotic Stewardship. Pediatr Infect Dis J 2017; 36:477.
  36. Puopolo KM, Mukhopadhyay S, Hansen NI, et al. Identification of Extremely Premature Infants at Low Risk for Early-Onset Sepsis. Pediatrics 2017; 140.
  37. Lancaster DP, Friedman DF, Chiotos K, Sullivan KV. Blood Volume Required for Detection of Low Levels and Ultralow Levels of Organisms Responsible for Neonatal Bacteremia by Use of Bactec Peds Plus/F, Plus Aerobic/F Medium, and the BD Bactec FX System: an In Vitro Study. J Clin Microbiol 2015; 53:3609.
  38. Singh MP, Balegar V KK, Angiti RR. The practice of blood volume submitted for culture in a neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed 2020; 105:600.
  39. Woodford EC, Dhudasia MB, Puopolo KM, et al. Neonatal blood culture inoculant volume: feasibility and challenges. Pediatr Res 2021; 90:1086.
  40. Sarkar SS, Bhagat I, Bhatt-Mehta V, Sarkar S. Does maternal intrapartum antibiotic treatment prolong the incubation time required for blood cultures to become positive for infants with early-onset sepsis? Am J Perinatol 2015; 32:357.
  41. Kuzniewicz MW, Mukhopadhyay S, Li S, et al. Time to Positivity of Neonatal Blood Cultures for Early-onset Sepsis. Pediatr Infect Dis J 2020; 39:634.
  42. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89:F229.
  43. Sharma D, Farahbakhsh N, Shastri S, Sharma P. Biomarkers for diagnosis of neonatal sepsis: a literature review. J Matern Fetal Neonatal Med 2018; 31:1646.
  44. Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:803.
  45. Lacaze-Masmonteil T, Rosychuk RJ, Robinson JL. Value of a single C-reactive protein measurement at 18 h of age. Arch Dis Child Fetal Neonatal Ed 2014; 99:F76.
  46. Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis J 1995; 14:362.
  47. Døllner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001; 54:1251.
  48. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104:447.
  49. Kawamura M, Nishida H. The usefulness of serial C-reactive protein measurement in managing neonatal infection. Acta Paediatr 1995; 84:10.
  50. Wasunna A, Whitelaw A, Gallimore R, et al. C-reactive protein and bacterial infection in preterm infants. Eur J Pediatr 1990; 149:424.
  51. Venkatesh M, Flores A, Luna RA, Versalovic J. Molecular microbiological methods in the diagnosis of neonatal sepsis. Expert Rev Anti Infect Ther 2010; 8:1037.
  52. Oeser C, Pond M, Butcher P, et al. PCR for the detection of pathogens in neonatal early onset sepsis. PLoS One 2020; 15:e0226817.
  53. Cantey JB, Baird SD. Ending the Culture of Culture-Negative Sepsis in the Neonatal ICU. Pediatrics 2017; 140.
  54. Cantey JB, Prusakov P. A Proposed Framework for the Clinical Management of Neonatal "Culture-Negative" Sepsis. J Pediatr 2022; 244:203.
  55. Sathyan S, Pournami F, Prithvi AK, et al. Optimizing antibiotic use in culture-negative healthcare-associated infection with a 'stop' policy: a descriptive analytical study. J Trop Pediatr 2022; 69.
  56. Vatne A, Hapnes N, Stensvold HJ, et al. Early Empirical Antibiotics and Adverse Clinical Outcomes in Infants Born Very Preterm: A Population-Based Cohort. J Pediatr 2023; 253:107.
  57. Letouzey M, Lorthe E, Marchand-Martin L, et al. Early Antibiotic Exposure and Adverse Outcomes in Very Preterm Infants at Low Risk of Early-Onset Sepsis: The EPIPAGE-2 Cohort Study. J Pediatr 2022; 243:91.
Topic 88740 Version 31.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟